TUBERCULOSIS AND CHRONIC RESPIRATORY DISEASE : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v8i12.1470Keywords:
Chronic Respiratory Disease, Inflammation, Pulmonary Disease, TuberculosisAbstract
Tuberculosis, also known as TB, is one of the most common infectious illnesses and has emerged as a major global public health concern. According to statistics provided by the World Health Organization (WHO), there are around 8.6 million new cases of tuberculosis each year, and the disease is responsible for 1.3 million fatalities. More than a half a million cases are documented in youngsters, and an estimated 320,000 fatalities are attributed to those who are infected with HIV. To this day, infectious diseases remain the leading cause of death across the globe, with tuberculosis being the infectious disease that is responsible for the greatest number of deaths overall. This is especially true in nations that are still developing and nations that are emerging. Despite the fact that tuberculosis can show in any organ or tissue, the respiratory system is the site where the illness is most commonly found to be actively spreading. Lungs and airways are both affected by disorders that affect the respiratory system. According to the World Health Organization (WHO), chronic respiratory diseases are responsible for the premature deaths of 4.6 million people each year, which accounts for more than 5% of global mortality. Approximately 90% of these deaths take place in low- and middle-income countries. The findings of this study's search suggested that the prevalence of individuals diagnosed with COPD was noticeably high among patients who had signs of pulmonary TB or who had recovered from pulmonary tuberculosis. There is a dearth of data about other disorders, such as bronchiectasis and bronchitis.
References
World Health Organization (WHO). WHO global tuberculosis report 2016. Geneva; 2017.
WHO. Global Tuberculosis Report 2019. 2019.
Schwartz N, Price S, Pratt R. Tuberculosis - United States. Morb Mortal Wkly Rep. 2020;69(11):286–9.
WHO. Global tuberculosis report 2021 [Internet]. World Health Organization. 2021. Tersedia pada: https://www.who.int/publications/digital/global-tuberculosis-report-2021
Kementerian Kesehatan Republik Indonesia. Infodatin. Jakarta; 2018.
Setiati S, Alwi I, Sudoyo AW, Sumadibrata M, Setiyohadi B, Syam AF. Buku Ajar Ilmu Penyakit Dalam. 6 ed. Jakarta: Interna Publishing; 2014.
Fishman JA, Grippi MA, Kotloff RM, et al. Fishman’s Pulmonary Disease and Disorders Fifth Edition. New York: Elsevier Saunder; 2016.
Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc lung Dis Off J Int Union against Tuberc Lung Dis. Juli 2008;12(7):703–8.
Lam KH, Jiang CQ, Jordan RE, Miller MR, Zhang W Sen, Cheng KK, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest. Maret 2010;137(3):593–600.
Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. Januari 2000;55(1):32–8.
Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease. Ann Intern Med. Agustus 2020;173(3):ITC17–32.
Fishman JA, Grippi MA, Kotloff RM, et al, Fishman JA, Grippi MA, Kotloff RM et al, Fishman JA, et al. Fishman’s Pulmonary Disease and Disorders Fifth Edition. New York: Elsevier Saunder; 2016.
Lee C-H, Lee M-C, Lin H-H, Shu C-C, Wang J-Y, Lee L-N, et al. Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS One [Internet]. 25 Mei 2012;7(5):e37978. Tersedia pada: https://doi.org/10.1371/journal.pone.0037978
Zhou Y, Wang C, Yao W, Chen P, Kang J, Huang S, et al. [The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China]. Zhonghua nei ke za zhi [Internet]. 2013;52(5):379–82. Tersedia pada: http://europepmc.org/abstract/MED/23945301
Amaral AFS, Coton S, Kato B, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. Oktober 2015;46(4):1104–12.
Choi CJ, Choi WS, Lee SY, Kim KS. The Definition of Past Tuberculosis Affects the Magnitude of Association between Pulmonary Tuberculosis and Respiratory Dysfunction: Korea National Health and Nutrition Examination Survey, 2008-2012. J Korean Med Sci. Mei 2017;32(5):789–95.
Dutta S, Deshmukh PR. Prevalence and determinants of self-reported chronic bronchitis among women in rural Central India. Med journal, Armed Forces India. Januari 2015;71(1):48–52.
Echazarreta AL, Arias SJ, Del Olmo R, Giugno ER, Colodenco FD, Arce SC, et al. Prevalence of COPD in 6 Urban Clusters in Argentina: The EPOC.AR Study. Arch Bronconeumol. Mei 2018;54(5):260–9.
Jain NK. Chronic obstructive pulmonary disease and tuberculosis. Lung India. 2017;34(5):468–9.
Hooper R, Burney P, Vollmer WM, McBurnie MA, Gislason T, Tan WC, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J. Juni 2012;39(6):1343–53.
Jain NK, Thakkar MS, Jain N, Rohan KA, Sharma M. Chronic obstructive pulmonary disease: Does gender really matter? Lung India. Oktober 2011;28(4):258–62.
Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76–85.
Chakrabarti B, Calverley PMA, Davies PDO. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2(3):263–72.
Holloway RA, Donnelly LE. Immunopathogenesis of chronic obstructive pulmonary disease. Curr Opin Pulm Med. Maret 2013;19(2):95–102.
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. Desember 2008;8(12):958–69.
Elkington PTG, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. Maret 2006;61(3):259–66.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Medical & Health Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
